The breakthrough designation cohort shows no signs of slowed growth, as the FDA grants 'all-hands-on-deck' attention to a total of 68 therapeutics.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
PowerPoint slides
Rights and permissions
About this article
Cite this article
Mullard, A. Breakthrough programme turns two. Nat Rev Drug Discov 13, 873–875 (2014). https://doi.org/10.1038/nrd4487
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4487
This article is cited by
-
2014 FDA drug approvals
Nature Reviews Drug Discovery (2015)
